Hospital
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals was paid $44.94M by Medicaid between Jan 2018 and Dec 2024, across 237 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.
33Billing provider infoKAISER FOUNDATION HOSPITALS
SAN LEANDRO, CA 94577
SAN LEANDRO, CA 94577
33aNPI1649605403assigned 09/11/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$44.94M
24GClaims931,111
24DCodes billed237
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#70 of 410
Median peer was paid$6.90M
This provider vs. median6.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49,967 | $601K | |
| 2019 | 86,508 | $620K | |
| 2020 | 88,113 | $5.32M | |
| 2021 | 120,655 | $7.33M | |
| 2022 | 160,563 | $9.69M | |
| 2023 | 184,498 | $10.64M | |
| 2024incomplete | 240,807 | $10.74M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 41,202 | 37,183 | $13.21M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 11,849 | 11,465 | $5.10M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.5% | 4,341 | 4,033 | $3.81M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.4% | 10,967 | 10,717 | $2.88M |
| G0378 | Hospital observation service, per hour | 5.4% | 4,485 | 3,137 | $2.41M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.6% | 5,925 | 5,808 | $2.06M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.8% | 14,112 | 13,700 | $1.70M |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 6,173 | 5,974 | $790K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 11,344 | 10,698 | $721K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 8,466 | 8,308 | $604K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 4,227 | 4,219 | $492K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.0% | 8,187 | 7,970 | $459K |
225 more codes
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,092 | $449K |
| 76830 | Ultrasound, transvaginal | <1% | 3,659 | $448K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 2,088 | $429K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,883 | $401K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,263 | $376K |
| 73630 | <1% | 3,118 | $261K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 334 | $257K |
| 36415 | Collection of venous blood by venipuncture | <1% | 40,751 | $245K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 241 | $242K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 775 | $219K |
| 73610 | <1% | 2,480 | $216K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 10,356 | $207K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 8,109 | $203K |
| 80051 | <1% | 32,311 | $192K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 738 | $185K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 47,439 | $181K |
| 99218 | <1% | 247 | $180K | |
| 73030 | <1% | 2,140 | $171K | |
| 0450 | Emergency room services | <1% | 3,995 | $170K |
| 73560 | <1% | 2,449 | $168K | |
| 59025 | Fetal non-stress test | <1% | 1,457 | $166K |
| 73564 | <1% | 1,206 | $160K | |
| 73130 | <1% | 2,000 | $159K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 15,280 | $154K |
| 72100 | <1% | 1,379 | $150K | |
| 0270 | <1% | 4,994 | $138K | |
| 99070 | <1% | 8,858 | $136K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 499 | $132K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 4,896 | $130K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,799 | $126K |
| 73110 | <1% | 1,440 | $125K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 293 | $123K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 121 | $120K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,373 | $119K |
| 93976 | <1% | 401 | $118K | |
| 99199 | Unlisted special service, procedure or report | <1% | 2,158 | $106K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,194 | $98K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,119 | $88K |
| 93971 | <1% | 710 | $88K | |
| 86900 | <1% | 3,025 | $88K | |
| 82565 | <1% | 39,194 | $87K | |
| 83880 | <1% | 4,939 | $70K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 599 | $69K |
| 73140 | <1% | 813 | $69K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,208 | $68K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 200 | $66K |
| 84702 | <1% | 5,711 | $66K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 460 | $65K |
| 73502 | <1% | 809 | $65K | |
| 82247 | <1% | 23,719 | $65K | |
| 81001 | <1% | 26,050 | $63K | |
| 84460 | <1% | 23,266 | $61K | |
| 73080 | <1% | 664 | $60K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 87 | $59K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,008 | $59K |
| 74018 | <1% | 632 | $58K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 18,026 | $56K |
| 76770 | <1% | 427 | $54K | |
| 76857 | <1% | 367 | $51K | |
| 70491 | <1% | 221 | $51K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,927 | $50K |
| 86850 | <1% | 2,673 | $49K | |
| 84450 | <1% | 20,505 | $46K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,202 | $46K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,784 | $45K |
| 83690 | <1% | 16,278 | $45K | |
| 82947 | <1% | 33,017 | $45K | |
| 72141 | <1% | 143 | $43K | |
| 84520 | <1% | 32,789 | $42K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,203 | $42K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,173 | $38K |
| 84075 | <1% | 18,459 | $37K | |
| 84484 | <1% | 9,493 | $37K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 300 | $37K |
| 70496 | <1% | 161 | $36K | |
| 83735 | <1% | 10,400 | $35K | |
| 73590 | <1% | 413 | $34K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,581 | $33K |
| 72040 | <1% | 327 | $32K | |
| 71250 | <1% | 284 | $31K | |
| 70486 | <1% | 190 | $30K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,000 | $29K |
| 76536 | <1% | 215 | $28K | |
| 70498 | <1% | 116 | $27K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,090 | $27K |
| 86901 | <1% | 3,026 | $26K | |
| 87631 | <1% | 763 | $24K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,533 | $23K |
| 85652 | <1% | 8,440 | $22K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,602 | $22K |
| 83605 | <1% | 4,836 | $21K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,313 | $21K |
| 81003 | <1% | 12,969 | $20K | |
| 73221 | <1% | 66 | $19K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,618 | $19K |
| 87040 | <1% | 3,992 | $19K | |
| 85610 | <1% | 8,734 | $18K | |
| 80306 | <1% | 2,234 | $18K | |
| J3490 | Unclassified drugs | <1% | 5,318 | $18K |
| 0637 | <1% | 59,664 | $16K | |
| 84132 | <1% | 3,379 | $16K | |
| 82248 | <1% | 3,302 | $16K | |
| 87088 | <1% | 5,021 | $15K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 6,230 | $14K |
| 0250 | <1% | 9,387 | $13K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,403 | $13K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,020 | $12K |
| 86923 | <1% | 151 | $12K | |
| 84100 | <1% | 4,612 | $12K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 874 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 620 | $11K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 12 | $11K |
| 82962 | <1% | 6,206 | $11K | |
| 82077 | <1% | 1,532 | $11K | |
| 84703 | <1% | 5,251 | $11K | |
| 73562 | <1% | 196 | $11K | |
| 82310 | <1% | 2,247 | $11K | |
| 85027 | <1% | 2,535 | $11K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 544 | $10K |
| 84295 | <1% | 1,898 | $9K | |
| 99221 | <1% | 222 | $9K | |
| 74183 | <1% | 12 | $9K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 109 | $9K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,518 | $8K |
| 96376 | <1% | 1,957 | $8K | |
| 73090 | <1% | 93 | $8K | |
| 87449 | <1% | 703 | $7K | |
| 0710 | <1% | 1,100 | $7K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 3,230 | $7K |
| 87324 | <1% | 690 | $7K | |
| 76870 | <1% | 58 | $7K | |
| 82040 | <1% | 1,534 | $7K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,625 | $6K |
| 85730 | <1% | 1,021 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 326 | $6K |
| 72070 | <1% | 45 | $5K | |
| 88307 | <1% | 12 | $5K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 393 | $5K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,321 | $5K |
| J1815 | Injection, insulin, per 5 units | <1% | 2,737 | $5K |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 412 | $5K |
| 85379 | <1% | 1,362 | $4K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 962 | $4K |
| 82803 | <1% | 720 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 136 | $4K |
| 86140 | <1% | 1,695 | $4K | |
| 73660 | <1% | 27 | $4K | |
| 80179 | <1% | 555 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,446 | $3K |
| 73522 | <1% | 22 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,799 | $3K |
| Z7502 | <1% | 487 | $3K | |
| 86780 | <1% | 420 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 707 | $3K |
| 82570 | <1% | 481 | $3K | |
| 72170 | <1% | 29 | $2K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 50 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 764 | $2K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $2K |
| 85378 | <1% | 624 | $2K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 646 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,211 | $1K |
| 0300 | <1% | 96 | $1K | |
| 84156 | <1% | 458 | $1K | |
| 82550 | <1% | 586 | $1K | |
| 73552 | <1% | 15 | $1K | |
| 43235 | <1% | 13 | $1K | |
| 96367 | <1% | 139 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 157 | $1K |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 406 | $1K |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 509 | $952.97 |
| 90686 | <1% | 138 | $938.89 | |
| 0370 | <1% | 990 | $890.22 | |
| 73600 | <1% | 57 | $799.58 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,006 | $785.69 |
| 83615 | <1% | 130 | $752.69 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 52 | $733.81 |
| 71101 | <1% | 15 | $730.33 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 39 | $709.68 |
| 87070 | <1% | 165 | $556.20 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 189 | $535.60 |
| 10060 | <1% | 12 | $485.69 | |
| 87081 | <1% | 190 | $471.07 | |
| 80069 | <1% | 62 | $460.54 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 190 | $444.38 |
| 73060 | <1% | 12 | $434.38 | |
| 85007 | <1% | 667 | $367.69 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 105 | $336.12 |
| 12001 | <1% | 41 | $306.00 | |
| 97161 | <1% | 112 | $302.21 | |
| 0301 | <1% | 1,141 | $280.33 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 53 | $247.20 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 13 | $204.00 |
| 85014 | <1% | 166 | $164.33 | |
| 82140 | <1% | 14 | $155.90 | |
| 85384 | <1% | 12 | $147.63 | |
| 12011 | <1% | 14 | $121.60 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 66 | $121.11 |
| G0008 | Administration of influenza virus vaccine | <1% | 149 | $115.53 |
| 90656 | <1% | 16 | $90.58 | |
| 73620 | <1% | 26 | $80.65 | |
| 96368 | <1% | 44 | $68.34 | |
| 86706 | <1% | 12 | $66.94 | |
| 80349 | <1% | 53 | $66.00 | |
| 87340 | <1% | 13 | $64.25 | |
| 85018 | <1% | 84 | $53.10 | |
| 80061 | Lipid panel | <1% | 27 | $50.84 |
| 80047 | <1% | 12 | $49.02 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 16 | $34.69 |
| 85008 | <1% | 215 | $31.14 | |
| 29515 | <1% | 12 | $30.00 | |
| 84550 | <1% | 12 | $27.03 | |
| 87205 | <1% | 12 | $21.92 | |
| Z7610 | <1% | 71 | $21.90 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 60 | $19.35 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 13 | $15.27 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 474 | $15.13 |
| 82728 | <1% | 12 | $15.00 | |
| 76376 | 0% | 145 | $0.00 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 44 | $0.00 |
| 80320 | 0% | 41 | $0.00 | |
| 97162 | 0% | 110 | $0.00 | |
| 0258 | 0% | 508 | $0.00 | |
| 0636 | 0% | 12 | $0.00 | |
| 80329 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANENBURG, THOMAS (SVP/AREA MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Hospitals | Fremont, CA | $19.94M |
| Kaiser Foundation Hospitals | Hayward, CA | $1.99M |
| Kaiser Foundation Hospitals | Union City, CA | $1.40M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.